CARM1 and cancer: However, the absence of extensive genomic and proteomic research to systematically uncover genomic binding sites, transcription targets, and cancer‐related substrates means the molecular mechanisms behind CARM1's regulation of oestrogen/ER‐mediated gene transcription activation are still not fully understood.